Domestic, foreign drug makers moving to join hands over low-priced drug incentive plan

Published: 2008-02-15 06:58:00

Updated: 2008-02-15 06:58:00

Korean drug makers and multinationals will be likely to join hands to cope with the government's plan to pass a bill aiming at introducing the controversial incentive system for medical institution's low-priced drug purchase in the National Assembly, although they have sparred over patent infring...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK